CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 265 enrolled
Drug / intervention
Strain isolation from the nasopharynxother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03197597
NCT03197597N/ACompleted
CompareCT.gov

EUpertstrain 4 Study of Bordetella Pertussis Isolates

University of Turku·observational·Posted Jun 23, 2017·Updated Jun 23, 2017

In Brief

An observational study evaluating Strain isolation from the nasopharynx for Bordetella Pertussis, Whooping Cough. Completed, enrolled 265 participants across 1 site.

Detailed Summary

This study focus on the genetic changes of B. pertussis clinical isolates. For this panels of B. pertussis isolates has been collected during four periods in different European countries.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBordetella Pertussis, Whooping Cough
CountriesFinland
CollaboratorsGlaxoSmithKline, Sanofi Pasteur, a Sanofi Company

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 23, 2017
Enrollment StartOct 12, 2015
Primary CompletionDec 31, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.0 years ago

Interventions

Strain isolation from the nasopharynxother

B. pertussis strains has been collected from the nasopharynx of the patients during the clinical visit